• English
  • Deutsch
  • Log In
    Password Login
    Research Outputs
    Fundings & Projects
    Researchers
    Institutes
    Statistics
Repository logo
Fraunhofer-Gesellschaft
  1. Home
  2. Fraunhofer-Gesellschaft
  3. Scopus
  4. The use of high-affinity polyhistidine binders as masking probes for the selection of an NDM-1 specific aptamer
 
  • Details
  • Full
Options
December 2022
Journal Article
Title

The use of high-affinity polyhistidine binders as masking probes for the selection of an NDM-1 specific aptamer

Abstract
The emergence of carbapenemase-producing multi-drug resistant Enterobacteriaceae poses a dramatic, world-wide health risk. Limited treatment options and a lack of easy-to-use methods for the detection of infections with multi-drug resistant bacteria leave the health-care system with a fast-growing challenge. Aptamers are single stranded DNA or RNA molecules that bind to their targets with high affinity and specificity and can therefore serve as outstanding detection probes. However, an effective aptamer selection process is often hampered by non-specific binding. When selections are carried out against recombinant proteins, purification tags (e.g. polyhistidine) serve as attractive side targets, which may impede protein target binding. In this study, aptamer selection was carried out against N-terminally hexa-histidine tagged New Delhi metallo-ß-lactamase 1. After 14 selection rounds binding to polyhistidine was detected rather than to New Delhi metallo-ß-lactamase 1. Hence, the selection strategy was changed. As one aptamer candidate showed remarkable binding affinity to polyhistidine, it was used as a masking probe and selection was restarted from selection round 10. Finally, after three consecutive selection rounds, an aptamer with specific binding properties to New Delhi metallo-ß-lactamase 1 was identified. This aptamer may serve as a much-needed detection probe for New Delhi metallo-ß-lactamase 1 expressing Enterobacteriaceae.
Author(s)
Sabrowski, Wiebke
Fraunhofer-Institut für Zelltherapie und Immunologie IZI  
Dreymann, Nico
Fraunhofer-Institut für Zelltherapie und Immunologie IZI  
Möller, Anja
Fraunhofer-Institut für Zelltherapie und Immunologie IZI  
Czepluch, Denise
Fraunhofer-Institut für Zelltherapie und Immunologie IZI  
Albani, P.P.
nal von minden GmbH
Theodoridis, D.
nal von minden GmbH
Menger, Marcus
Fraunhofer-Institut für Zelltherapie und Immunologie IZI  
Journal
Scientific Reports  
Open Access
DOI
10.1038/s41598-022-12062-2
Additional link
Full text
Language
English
Fraunhofer-Institut für Zelltherapie und Immunologie IZI  
  • Cookie settings
  • Imprint
  • Privacy policy
  • Api
  • Contact
© 2024